Meningioma has been recognized as the most common primary intracranial tumor and accounts for 30% of all central nervous system tumors, with an annual incidence of 5/100,000 1,2,3. According to the ...

Neurofibromatosis 2 (NF2) is a rare genetic disorder that causes noncancerous tumors on nerves in the brain and spinal cord. These tumors can affect hearing, vision, and balance. About half of the ...

This review will discuss the contribution of merlin loss of function in NF2-related tumors and common human cancers and the molecular mechanisms that lead to tumorigenesis, tumor progression or ...

Neurofibromatosis type 2 is caused by a change in the NF2 gene located on chromosome 22. This gene encodes a protein known as merlin. Mutations in the NF2 gene disrupt the function of merlin, which is ...

Additional symptoms of NF2 can include facial weakness, headache, changes in vision, weakness of part of the body, pain, and sensory loss. Cataracts or other types of eye problems can also develop in ...

Patients with a genetic syndrome called NF2-related schwannomatosis (NF2-SWN) have tumors that develop on the covering of the brain or grow along the nerves in the brain, spinal cord, and/or other ...

The proteins that provide cells with a sense of personal space could lead to a therapeutic target for Neurofibromatosis Type 2 (NF2), an inherited cancer disorder, according to researchers at The ...

Neurofibromatosis is a group of rare genetic disorders that cause benign tumors to form on nerve tissue. Tumors in this disorder are usually noncancerous (benign), but can sometimes become cancerous ...

Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials VEGFR1 and VEGFR2 peptides were injected subcutaneously into ...